Clinical Trials Directory

Trials / Completed

CompletedNCT04461002

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of WHO II and III Grade Incident Gliomas.

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and preoperative imaging data (by FDG and FDOPA PET-scan and multimodal MRI).

Detailed description

A retrospective monocentre study of medical data (clinical, histological, molecular and imaging) contained in the medical records of patients operated on for Grade II or III incident glioma.

Conditions

Interventions

TypeNameDescription
OTHERRetrospective analysisEvaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI).

Timeline

Start date
2019-09-30
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2020-07-08
Last updated
2024-07-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04461002. Inclusion in this directory is not an endorsement.

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Inciden (NCT04461002) · Clinical Trials Directory